Gene · 5873
Papers3,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging Potential of Exosomal Non-coding RNA in Parkinson's Disease: A Review. | Front Aging Neurosci | 2022 | 35360206 | PubTator, text mining | PubMed |
| DNA in extracellular vesicles: from evolution to its current application in health and disease. | Cell Biosci | 2022 | 35346363 | PubTator, text mining | PubMed |
| Current methods to analyze lysosome morphology, positioning, motility and function. | Traffic | 2022 | 35343629 | PubTator, text mining | PubMed |
| Regenerative therapy by using mesenchymal stem cells-derived exosomes in COVID-19 treatment. The potential role and underlying mechanisms. | Regen Ther | 2022 | 35340407 | PubTator, text mining | PubMed |
| Methamphetamine Induces the Release of Proadhesive Extracellular Vesicles and Promotes Syncytia Formation: A Potential Role in HIV-1 Neuropathogenesis. | Viruses | 2022 | 35336957 | PubTator, text mining | PubMed |
| Hemophagocytic Lymphohistiocytosis Gene Variants in Multisystem Inflammatory Syndrome in Children. | Biology (Basel) | 2022 | 35336791 | PubTator, text mining | PubMed |
| Exosome Processing and Characterization Approaches for Research and Technology Development. | Adv Sci (Weinh) | 2022 | 35332686 | PubTator, text mining | PubMed |
| The Fight against Cancer by Microgravity: The Multicellular Spheroid as a Metastasis Model. | Int J Mol Sci | 2022 | 35328492 | PubTator, text mining | PubMed |
| Circ_0058063 contributes to cisplatin-resistance of bladder cancer cells by upregulating B2M through acting as RNA sponges for miR-335-5p. | BMC Cancer | 2022 | 35321689 | PubTator, text mining | PubMed |
| Myeloid Responses to Extracellular Vesicles in Health and Disease. | Front Immunol | 2022 | 35320943 | PubTator, text mining | PubMed |
| Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response. | J Exp Clin Cancer Res | 2022 | 35317831 | PubTator, text mining | PubMed |
| Emerging function and clinical significance of extracellular vesicle noncoding RNAs in lung cancer. | Mol Ther Oncolytics | 2022 | 35317517 | PubTator, text mining | PubMed |
| Neutrophils Require Activation to Express Functional Cell-Surface Complement Receptor Immunoglobulin. | Front Immunol | 2022 | 35317169 | PubTator, text mining | PubMed |
| Secondary Hemophagocytic Lymphohistiocytosis in a Post-COVID-19 Patient. | Cureus | 2022 | 35317032 | PubTator, text mining | PubMed |
| Hypoxia preconditioning elicit differential response in tissue-specific MSCs via immunomodulation and exosomal secretion. | Cell Tissue Res | 2022 | 35316374 | PubTator, text mining | PubMed |
| System Xc- inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance. | Cancer Lett | 2022 | 35315341 | PubTator, text mining | PubMed |
| Multisystem Inflammatory Syndrome in Adults or Hemophagocytic Lymphohistiocytosis: A Clinical Conundrum in Fully Vaccinated Adults With Breakthrough COVID-19 Infections. | Cureus | 2022 | 35308726 | PubTator, text mining | PubMed |
| Urinary bladder metastasis from primary breast cancer, a rare and challenging diagnosis. A case report and literature review. | Ann Med Surg (Lond) | 2022 | 35308426 | PubTator, text mining | PubMed |
| Identification of the first structurally validated covalent ligands of the small GTPase RAB27A. | RSC Med Chem | 2022 | 35308027 | Swiss-Prot, curated | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5873/papers?page=49